Mechanisms of enveloped virus entry into animal cells

Advanced Drug Delivery Reviews

Volumn 34, Issue 1, 1998, Pages 65-91

  Klasse, Per Johan ^a   Bron, Romke ^a   Marsh, Mark ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Endocytosis; Enveloped viruses; Membrane fusion; Virus entry; Virus fusion; Virus receptors; Viruses

Indexed keywords

CELL MEMBRANES; MACROMOLECULES; MASS TRANSFER; MOLECULAR DYNAMICS;

ENDOCYTOSIS;

VIRUSES;

CELL DNA; CLATHRIN; VIRUS DNA; VIRUS FUSION PROTEIN; VIRUS RECEPTOR;

BIOTECHNOLOGY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; EXPRESSION VECTOR; GENE TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; MEMBRANE TRANSPORT; NONHUMAN; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL; RETROVIRUS; REVIEW; SEMLIKI FOREST ALPHAVIRUS; VIRUS ADSORPTION; VIRUS DNA CELL DNA INTERACTION; VIRUS ENVELOPE;

EID: 0032487332     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00002-7     Document Type: Review

References (261)

1. Adams L.D., Tomasselli A.G., Robbins P., Moss B., Heinrikson R.L. HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. AIDS Res. Hum. Retroviruses. 8:1992;291-295.
2. Albritton L.M., Tseng L., Scadden D., Cunningham J.M. A putative murine retrovirus receptor gene encodes a multiple membrane spanning protein and confers susceptibility to virus infection. Cell. 57:1989;659-666.
3. Allison S.L., Schalich J., Stiasny K., Mandl C.W., Kunz C., Heinz F.X. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J. Virol. 69:1995;695-700.
4. Andersen K.B., Skov H. Retrovirus-induced cell fusion is enhanced by protease treatment. J. Gen. Virol. 70:1989;1921-1927.
5. Anderson H.A., Chen Y., Norkin L.C. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell. 7:1996;1825-1834.
6. Anderson R.G.W. Potocytosis of small molecules and ions by caveolae. Trends Cell Biol. 3:1993;69-72.
7. Anderson W.F. Human gene therapy. Science. 256:1992;808-813.
8. Anthony R.P., Brown D.T. Protein-protein interactions in an alphavirus membrane. J. Virol. 65:1991;1187-1194.
9. Arthur L.O., Bess J.W. Jr., Sowder R.C.d., Benveniste R.E., Mann D.L., Chermann J.C., Henderson L.E. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science. 258:1992;1935-1938.
10. Ashorn P.A., Berger E.A., Moss B. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cell. J. Virol. 64:1990;2149-2156.
11. Atwood W.J., Norkin L.C. Class I major histocompatibility proteins as cell surface receptors for simian virus 40. J. Virol. 63:1989;4474-4477.
12. Ban J., Portetelle D., Altaner C., Horion B., Milan D., Krchnak V., Burny A., Kettmann R. Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor. J. Virol. 67:1993;1050-1057.
13. Bates P., Young J.A., Varmus H.E. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell. 74:1993;1043-1051.
14. J. Bentz, Viral Fusion Mechanisms, CRC Press, Boca Raton, FL, 1993.
15. Beron W., AlvarezDominguez C., Mayorga L., Stahl P.D. Membrane trafficking along the phagocytic pathway. Trends Cell Biol. 5:1995;101-104.
16. Berson J.F., Long D., Doranz B.J., Rucker J., Jirik F.R., Doms R.W. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J. Virol. 70:1996;6288-6295.
17. Bhat S., Spitalnik S.L., Gonzalez-Scarano F., Silberberg D.H. Galactosylceramide or a molecule derived from it is an essential component of the neural receptor for HIV-1 envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA. 88:1991;7131-7139.
18. Blacklow S.C., Lu M., Kim P.S. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry. 34:1995;14955-14962.
19. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for Lestr/fusin and blocks HIV-1 entry. Nature (London). 382:1996;829-832.
20. Blumenthal R., Sarkar D.P., Durell S., Howard D.E., Morris S.J. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetis of individual cell-cell fusion events. J. Cell Biol. 135:1996;63-71.
21. Blumenthal R., Schoch C., Puri A., Clague M.J. A dissection of steps leading to viral envelope protein-mediated membrane fusion. Ann. N.Y. Acad. Sci. 635:1991;285-296.
22. Bourinbaiar A.S., Phillips D.M. Transmission of human immunodeficiency virus from monocytes to epithelia. J. AIDS. 4:1991;56-63.
23. Boycott R., Klenk H.D., Ohuchi M. Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. Virology. 203:1994;313-319.
24. Braakman I., Hoover-Litty H., Wagner K.R., Helenius A. Folding of Influenza hemagglutinin in the endoplasmic reiculum. J. Cell Biol. 114:1991;401-411.
25. Breau W.C., Atwood W.J., Norkin L.C. Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J. Virol. 66:1992;2037-2045.
26. Bron R., Kendal A.P., Klenk H.D., Wilschut J. Role of the M2 protein in influenza virus membrane fusion: Effects of amantadine and monensin on fusion kinetics. Virology. 195:1993;808-811.
27. Bron R., Ortiz A., Wilschut J. Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes). Biochemistry. 33:1994;9110-9117.
28. Bron R., Wahlberg J.M., Garoff H., Wilschut J. Membrane fusion of Semliki Forest virus in a model system: Correlation between fusion kinetics and structural changes in the envelope glycoprotein. EMBO J. 12:1993;693-701.
29. Bullough P.A., Hughson F.M., Skehel J.J., Wiley D.C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 371:1994;37-43.
30. Cameron P.U., Lowe M.G., Crowe S.M., O'Doherty U., Pope M., Gezelter S., Steinman R.M. Susceptibility of dendritic cells to HIV-1 infection in vitro. J. Leukocyte Biol. 56:1994;257-265.
31. Carr C., Kim P. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:1993;823-832.
32. Chan D.C., Fass D., Berger J.M., Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263-273.
33. Chen Z., Zhou P., Ho D.D., Landau N.R., Marx P.A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71:1997;2705-2714.
34. Chesebro B., Buller R., Portis J., Wehrly K. Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J. Virol. 64:1990;215-221.
35. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., LaRosa M.C.R.G., Newman W., Gerard N., Gerard C., Sodroski J. The β-Chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
36. Choi H.-K., Tong L., Minor W., Dumas P., Boege U., Rossmann M.G., Wengler G. Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organisation of the virion. Nature. 354:1991;37-43.
37. Ciampor F., Bayley P.M., Nermut M.V., Hirst E., Sugrue R.J., Hay A.J. Evidence that the amantadine-induced, M2-mediated conversion of influenza-A virus hemagglutinin to the low pH conformation occurs in an acidic trans-golgi compartment. Virology. 188:1992;14-24.
38. Clague M.J., Schoch C., Blumenthal R. Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density. J. Virol. 65:1991;2402-2407.
39. M.J. Clague, S. Urbe, F. Aniento, J. Gruenberg, Vacuolar ATPase activity is required for endosomal carrier vesicle formation, J. Biol. Chem. (1994) 21-24.
40. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270:1995;1811-1815.
41. Collins A.R. HLA class I antigen serves as a receptor for human coronavirus OC43. Immunol. Invest. 22:1993;95-103.
42. Compton T., Nowlin D.M., Cooper N.R. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology. 193:1993;834-841.
43. Corver J., Moesby L., Erukulla R.K., Reddy K.C., Bittman R., Wilschut J. Sphingolipid-dependent fusion of Semliki Forest virus with cholesterol-containing liposomes requires both the 3-hydroxyl group and the double bond of the sphingolipid backbone. J. Virol. 69:1995;3220-3223.
44. Cosset F.L., Morling F.J., Takeuchi Y., Weiss R.A., Collins M.K., Russell S.J. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69:1995;6314-6322.
45. Cupers P., Veithen A., Baudhuin P., Courtoy P.J. Clathrin polymerization is not required for bulk-phase endocytosis in rat foetal fibroblasts. J. Cell Biol. 127:1994;725-736.
46. Dalgleish A.G., Beverley P.C.L., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763-767.
47. Dalziel R.G., Hopkins J., Watt N.J., Dutia B.M., Clarke H.A., McConnell I. Identification of a putative cellular receptor for the lentivirus visna virus. J. Gen. Virol. 72:1991;1905-1911.
48. Damke H., Baba T., Warnock D.E., Schmid S.L. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell Biol. 127:1994;915-934.
49. Danieli T., Pelletier S.L., Henis Y.I., White J.M. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 133:1996;559-569.
50. de Curtis J., Simons K. Dissection of Semliki Forest virus glycoprotein delivery from the trans-Golgi network to the cell surface in permeabilized BHK cells. Proc. Natl. Acad. Sci. USA. 85:1988;8052-8056.
51. Delmas B., Gelfi J., L'Haridon R., Vogel L.K., Sjöström H., Norén O., Laude H. Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV. Nature. 357:1992;417-420.
52. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
53. Dimitrov D.S., Hillman K., Manischewitz J., Blumenthal R., Golding H. Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: Implications for mechanisms of cell fusion and therapy for AIDS. AIDS. 6:1992;249-256.
54. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S., Parmentier M., Collman R.J., Doms R.W. A dual-tropic, primary HIV-1 isolate that uses Fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
55. Dorig R.E., Marcil A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 75:1993;295-305.
56. Dragic T., Charneau P., Clavel F., Alizon M. Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J. Virol. 66:1992;4794-4802.
57. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
58. Duffus W.A., Levymintz P., Klimjack M.R., Kielian M. Mutations in the putative fusion peptide of Semliki forest virus affect spike protein oligomerization and virus assembly. J. Virol. 69:1995;2471-2479.
59. +-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J. Biol. Chem. 271:1996;13417-13421.
60. Ellens H., Bentz J., Mason D., Zhang F., White J.M. Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes - role of hemagglutinin surface density. Biochemistry. 29:1990;9697-9707.
61. H. Ellens, C. Larsen, CD4-induced changes in gp120/gp41 confomation and its potential relationship to fusion, in: J. Bentz (Ed.), Viral Fusion Mechanisms, CRC Press, Boca Raton, 1993, pp. 291-312.
62. Endres M.J., Clapham P.R., Marsh M., Ahuja M., Davis-Turner J., McKnight A., Thomas J., Stoebenau-Haggarty B., Choe S., Vance P.J., Wells T.N.C., Power C.A., Sutterwala S.S., Doms R.W., Landau N.R., Hoxie J.A. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell. 87:1996;745-756.
63. Eppstein D.A., Marsh Y.V., Schreiber A.B., Newman S.R., Todaro G.J., Nestor J.J. Jr. Epidermal growth factor receptor occupancy inhibits vaccinia virus infection. Nature. 318:1985;663-665.
64. Fass D., Harrison S.C., Kim P.S. Retrovirus envelope domain at 1.7 angstrom resolution. Nat. Struct. Biol. 3:1996;465-469.
65. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane. G protein-coupled receptor. Science. 272:1996;872-877.
66. Fingeroth J.D., Weis J.J., Tedder T.F., Strominger J.L., Biro P.A., Fearon D.T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA. 81:1984;4510-4514.
67. Flynn D.C., Meyer W.J., MacKenzie J.M., Johnston R.E. A conformational change in Sindbis virus glycoproteins E1 and E2 is detected at the plasmamembrane as a consequence of early virus-cell interaction. J. Virol. 64:1990;3643-3653.
68. Frade R., Barel M., Ehlin Henriksson B., Klein G. gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor. Proc. Natl. Acad. Sci. USA. 82:1985;1490-1493.
69. Froshauer S., Kartenbeck J., Helenius A. Alphavirus RNA replicase is located on the cytoplasmic surface of endosomes and lysosomes. J. Cell Biol. 107:1988;2075-2086.
70. Fu Y.K., Hart T.K., Jonak Z.L., Bugelski P.J. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. J. Virol. 67:1993;3818-3825.
71. Fuller S.D. The T=4 envelope of Sindbis virus is organized by interactions with a complementary T=3 capsid. Cell. 48:1987;923-934.
72. Fuller S.D., Berriman J.A., Butcher S.J., Gowen B.E. Low pH induces swiveling of the glycoprotein heterodimers in the Semliki-forest virus spike complex. Cell. 81:1995;715-725.
73. Gallay P., Stitt V., Mundy C., Oettinger M., Trono D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70:1996;1027-1032.
74. Gelderblom H.R. Fine structure, antigenic composition and functional aspects of the AIDS virus (HIV). Zeiss-Inform. 5:1987;46-50.
75. Gilbert J.M., Hernandez L.D., Balliet J.W., Bates P., White J.M. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J. Virol. 69:1995;7410-7415.
76. Godley L., Pfeifer J., Steinhauer D., Ely B., Shaw G., Kaufmann R., Suchanek E., Pabo C., Skehel J.J., Wiley D.C., Wharton S. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell. 68:1992;635-645.
77. Grambas S., Bennett M.S., Hay A.J. Influence of amantadine resistance mutations on the pH regulatory function of the M2-protein of influenza-A viruses. Virology. 191:1992;541-549.
78. Greber U.F., Singh I., Helenius A. Mechanisms of virus uncoating. Trends Microbiol. 2:1994;52-56.
79. Greber U.F., Willetts M., Webster P., Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell. 75:1993;477-486.
80. Gruenberg J., Maxfield F.R. Membrane transport in the endocytic pathway. Curr. Opin. Cell Biol. 7:1995;552-563.
81. Guy H.R., Durell S.R., Schoch C., Blumenthal R. Analyzing the fusion process of influenza hemagglutinin by mutagenesis and molecular modeling. Biophys. J. 62:1992;95-97.
82. Harouse J.M., Bhat S., Spitalnik S.L., Laughlin M., Stefano K., Silberberg D.H., Gonzalez Scarano F. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science. 253:1991;320-323.
83. Helenius A. Unpacking the incoming influenza virus. Cell. 69:1992;577-578.
84. Helenius A., Kartenbeck J., Simons K., Fries E. On the entry of Semliki Forest virus into BHK-21 cells. J. Cell Biol. 84:1980;404-420.
85. Helenius A., Marsh M., White J. Effect of lysosomotropic weak bases on Semliki Forest virus penetration into host cells. J. Gen. Virol. 58:1982;47-61.
86. Helenius A., Morein B., Fries E., Simons K., Robinson P., Schirrmacher V., Terhorst C., Strominger J.L. Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus. Proc. Natl. Acad. Sci. USA. 75:1978;3846-3850.
87. Herrler G., Rott R., Klenk H.D. Neuraminic acid is involved in the binding of influenza C virus to erythrocytes. Virology. 141:1985;144-147.
88. Herrler G., Rott R., Klenk H.D., Muller H.P., Shukla A.K., Schauer R. The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J. 4:1985;1503-1516.
89. Hiebsch R.R., Raub T.J., Wattenberg B.W. Primaquine blocks transport by inhibiting the formation of functional transport vesicles. Studies in a cell-free assay of protein transport through the Golgi apparatus. J. Biol. Chem. 266:1991;20323-20328.
90. Holsinger L.J., Lamb R.A. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulphide bonds. Virology. 183:1991;32-43.
91. Huet C., Ash J.F., Singer S.J. The antibody-induced clustering and endocytosis of HLA antigens on cultured human fibroblsts. Cell. 21:1980;429-438.
92. Inada T., Mims C.A. Mouse Ia antigens are receptors for lactate dehydrogenase virus. Nature. 309:1984;59-61.
93. Johann S.V.G.J.J., O'Hara B. GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus. J. Virol. 66:1992;1635-1640.
94. Kartenbeck J., Stukenbrok H., Helenius A. Endocytosis of simian virus 40 into the endoplasmic reticulum. J. Cell Biol. 109:1989;2721-2729.
95. Kavanaugh M.P., Miller D.G., Zhang W., Law W., Kozak S.L., Kabat D., Miller A.D. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA. 91:1994;7071-7075.
96. Kemble G.W., Bodian D.L., Rosé J., Wilson I.A., White J.M. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin. J. Virol. 66:1992;4940-4950.
97. Kemble G.W., Danieli T., White J.M. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell. 76:1994;383-391.
98. M. Kielian, Membrane fusion activity of alphaviruses, in: J. Bentz (Ed.), Viral Fusion Mechanisms, CRC Press, Boca Raton, FL, 1993, pp. 385-412.
99. Kielian M., Helenius A. Role of cholesterol in fusion of Semliki forest virus with membranes. J. Virol. 52:1984;281-283.
100. Kielian M., Helenius A. pH-induced alterations in the fusogenic spike protein of Semliki Forest virus. J. Cell Biol. 101:1985;2284-2291.
101. Kielian M., Jungerwirth S., Ulrich Sayad K., De Candido S. Biosynthesis, maturation, and acid activation of the Semliki Forest virus fusion protein. J. Virol. 64:1990;4614-4624.
102. Kielian M.C., Marsh M., Helenius A. Kinetics of endosome acidification detected by mutant and wild-type Semliki Forest virus. EMBO J. 5:1986;3103-3109.
103. Klasse P.J., Pipkorn R., Blomberg J., Han K.H., Hilton B., Ferretti J.A. Three-dimensional structure and antigenicity of transmembrane-protein peptides of the human immunodeficiency virus type 1. Effects of a neutralization-escape substitution. FEBS Lett. 323:1993;68-72.
104. Klasse P.J., Moore J.P. Kinetics of the HIV-CD4 interactions and virus-cell fusion. AIDS. 6:1992;325-327.
105. Klatzman D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.-C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 312:1984;767-768.
106. Knight S.C., Macatonia S.E., Patterson S. HIV I infection of dendritic cells. Int. Rev. Immunol. 6:1990;163-175.
107. Koike S., Ise I., Sato Y., Mitsui K., Umeyama H., Nomoto A. Early events of poliovirus infection. Semin. Virol. 3:1992;109-115.
108. Lentz T.L. Rabies virus binding to an acetylcholine receptor alpha-subunit peptide. J. Mol. Recog. 3:1990;82-88.
109. Lentz T.L. Structure-function relationships of curaremimetic neurotoxin loop 2 and of a structurally similar segment of rabies virus glycoprotein in their interaction with the nicotinic acetylcholine receptor. Biochemistry. 30:1991;10949-10957.
110. Levy-Mintz P., Kielian M. Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein. J. Virol. 65:1991;4292-4300.
111. Li J.P., Hu H.O., Niu Q.T., Fang C. Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55. J. Virol. 69:1995;1714-1719.
112. Lisanti M.P., Tang Z.L., Scherer P.E., Kubler E., Koleske A.J., Sargiacomo M. Caveolae, transmembrane signalling and cellular transformation. Mol. Membr. Biol. 12:1995;121-124.
113. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald S.R., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
114. Lobigs M., Garoff H. Fusion function of the Semliki Forest virus spike is activated by proteolytic cleavage of the envelope glycoprotein precursor p62. J. Virol. 64:1990;1233-1240.
115. Lobigs M., Wahlberg J.M., Garoff H. Spike protein oligomerization control of Semliki Forest virus fusion. J. Virol. 64:1990;5214-5218.
116. Lu M., Blacklow S.C., Kim P.S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1995;1075-1082.
117. Lusso P., Secchiero P., Crowley R.W., Garzino Demo A., Berneman Z.N., Gallo R.C. CD4 is a critical component of the receptor for human herpesvirus 7: Interference with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 91:1994;3872-3876.
118. Machy P., Truneh A., Gennaro D., Hoffstein S. Major histocompatibility complex class I molecules internalized via coated pits in T lymphocytes. Nature. 328:1987;724-726.
119. Maddon P.J., Dalgleish A.G., McDougal J.S., Clapham P.R., Weiss R.A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47:1986;333-348.
120. Marcon L., Choe H., Martin K.A., Farzan M., Ponath P.D., Wu L., Newman W., Gerard N., Gerard C., Sodroski J. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J. Virol. 71:1997;2522-2527.
121. Marin M., Noel D., Valsesia Wittman S., Brockly F., Etienne Julan M., Russell S., Cosset F.L., Piechaczyk M. Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. J. Virol. 70:1996;2957-2962.
122. Marquardt T., Hebert D.N., Helenius A. Post-translational folding of influenza hemagglutinin in isolated endoplasmic reticulum-derived microsomes. J. Biol. Chem. 268:1993;19618-19625.
123. Marsh M., Bron R. SFV infection in CHO cells: Cell-type specific restrictions to productive virus entry at the cell surface. J. Cell Sci. 110:1997;95-103.
124. Marsh M., Helenius A. Adsorptive endocytosis of Semliki Forest virus. J. Mol. Biol. 142:1980;439-454.
125. Martin K., Helenius A. Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import. Cell. 67:1991;117-130.
126. Martin K., Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J. Virol. 65:1991;232-244.
127. Matlin K.S., Reggio H., Helenius A., Simons K. Pathway of vesicular stomatitis virus entry leading to infection. J. Mol. Biol. 156:1982;609-631.
128. Matthews T.J., Wild C., Chen C.H., Bolognesi D.P., Greenberg M.L. Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140:1994;93-104.
129. McClure M.O., Marsh M., Weiss R.A. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J. 7:1988;513-518.
130. McClure M.O., Sommerfelt M.A., Marsh M., Weiss R.A. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71:1990;767-773.
131. Melikyan G.B., Brener S.A., Ok D.C., Cohen F.S. Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J. Cell Biol. 136:1997;995-1005.
132. Metsikkö K., Garoff H. Oligomers of the cytoplasmic domain of the p62/E2 membrane protein of Semliki Forest virus bind to the nucleocapsid in vitro. J. Virol. 64:1990;4678-4683.
133. Meyer W.J., Gidwitz S., Ayers V.K., Schoepp R.J., Johnston R.E. Conformational alterations of Sindbis virion glycoproteins induced by heat, reducing agents, or low pH. J. Virol. 66:1992;3504-3513.
134. Meyer W.J., Johnston R.E. Structural rearrangement of infecting Sindbis virions at the cell surface - Mapping of newly accessible epitopes. J. Virol. 67:1993;5117-5125.
135. Miller A.D. Human gene therapy comes of age. Nature. 357:1992;455-460.
136. Miller D.G., Miller A.D. A family of retroviruses that utilize related phosphate transporters for cell entry. J. Virol. 68:1994;8270-8276.
137. Miller N., Hutt Fletcher L.M. Epstein-Barr virus enters B cells and epithelial cells by different routes. J. Virol. 66:1992;3409-3414.
138. Moesby L., Corver J., Erukulla R.K., Bittman R., Wilschut J. Sphingolipids activate membrane-fusion of semliki-forest-virus in a stereospecific manner. Biochemistry. 34:1995;10319-10324.
139. Montgomery R.I., Warner M.S., Lum B.J., Spear P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 87:1996;427-436.
140. Moore J.P., Klasse P.J. Thermodynamic and kinetic analysis of sCD4 binding to HIV-1 virions and of gp120 dissociation. AIDS Res. Hum. Retroviruses. 8:1992;443-450.
141. Moore J.P., McKeating J.A., Weiss R.A., Sattentau Q.J. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science. 250:1990;1139-1142.
142. Moore J.P., Sodroski J. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J. Virol. 70:1996;1863-1872.
143. Moore J.P., Trkola A., Dragic T. Co-receptors for HIV-1 entry. Curr. Biol. Opin. Immunol. 9:1997;551-562.
144. Moore M.D., Cannon M.J., Sewall A., Finlayson M., Okimoto M., Nemerow G.R. Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats. J. Virol. 65:1991;3559-3565.
145. Mulligan R.C. The basic science of gene therapy. Science. 260:1993;926-932.
146. Naniche D., Varior Krishnan G., Cervoni F., Wild T.F., Rossi B., Rabourdin Combe C., Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:1993;6025-6032.
147. Nemerow G.R., Moore M.D., Cooper N.R. Structure and function of the B-lymphocyte Epstein-Barr virus/C3d receptor. Adv. Cancer Res. 54:1990;273-300.
148. Nemerow G.R., Wolfert R., McNaughton M.E., Cooper N.R. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J. Virol. 55:1985;347-351.
149. Nieva J.L., Bron R., Corver J., Wilschut J. Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J. 13:1994;2797-2804.
150. Norbury C.C., Chambers B.J., Prescott A.R., Ljunggren H.G., Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27:1997;280-288.
151. Norbury C.C., Hewlett L.J., Prescott A.R., Shastri N., Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity. 3:1995;783-791.
152. Oberlin E., Amara A., Bacherlerie F., Bessia C., Virelizier J.-L., Arenzana-Seisdedos F., Schwartz O., Heard J.-M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for Lestr/Fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (London). 382:1996;833-835.
153. Olah Z., Lehel C., Anderson W.B., Eiden M.V., Wilson C.A. The cellular receptor for gibbon ape leukemia virus is a novel high affinity sodium-dependent phosphate transporter. J. Biol. Chem. 269:1994;25426-25431.
154. Oldstone M.B.A., Tishon A., Dutko F., Kennedy S.I.T., Holland J.J., Lampert P.W. Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus. J. Virol. 34:1980;256-265.
155. Olson N.H., Kolatkar P.R., Oliveira M.A., Cheng R.H., Greve J.M., McClelland A., Baker T.S., Rossmann M.G. Structure of a human rhinovirus complexed with its receptor molecule. Proc. Natl. Acad. Sci. USA. 90:1993;507-511.
156. Orloff G.M., Orloff S.L., Kennedy M.S., Maddon P.J., McDougal J.S. Penetration of CD4 T cells by HIV-1. The CD4 receptor does not internalise with HIV, and CD4-related signal transduction events are not required for entry. J. Immunol. 146:1991;2578-2587.
157. Panetti T.S., McKeown-Longo P.J. The alpha v beta 5 integrin receptor regulates receptor-mediated endocytosis of vitronectin. J. Biol. Chem. 268:1993;11492-11495.
158. Panetti T.S., McKeown-Longo P.J. Receptor-mediated endocytosis of vitronectin is regulated by its conformational state. J. Biol. Chem. 268:1993;11988-11993.
159. Paredes A.M., Brown D.T., Rothnagel R., Chiu W., Schoepp R.J., Johnston R.E., Prasad B.V.V. 3-Dimensional structure of a membrane-containing virus. Proc. Natl. Acad. Sci. USA. 90:1993;9095-9099.
160. Paredes A.M., Simon M.N., Brown D.T. The mass of the Sindbis virus nucleocapsid suggests it has T=4 icosahedral symmetry. Virology. 187:1992;329-332.
161. Parton R.G. Caveolae and caveolins. Curr. Opin. Cell Biol. 8:1996;542-548.
162. Parton R.G., Joggerst B., Simons K. Regulated internalization of caveolae. J. Cell Biol. 127:1994;1199-1215.
163. Patterson S., Oxford J.S., Dourmashkin R.R. Studies on the mechanism of influenza virus entry into cells. J. Gen. Virol. 43:1979;223-229.
164. Paxton W.A., Martin S.R., Tse D., O'Brien T.R., Skurnick J., VanDevanter N.L., Padian N., Braun J.F., Kotler D.P., Wolinsky S.M., Koup R.A. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 2:1996;412-417.
165. Pelchen-Matthews A., Clapham P., Marsh M. The role of CD4 endocytosis in HIV infection. J. Virol. 69:1995;8164-8168.
166. Pettersson R.F. Protein localization and virus assembly at intracellular membranes. Curr. Top. Microbiol. Immunol. 170:1991;67-106.
167. Phalen T., Kielian M. Cholesterol is required for infection by Semliki Forest virus. J. Cell Biol. 112:1991;615-623.
168. Pinto L.H., Holsinger L.J., Lamb R.A. Influenza M2 protein has ion channel activity. Cell. 69:1992;517-528.
169. Plank C., Oberhauser B., Mechtler K., Koch C., Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269:1994;12918-12924.
170. Power C.A., Wells T.N.C. Cloning and characterisation of human chemokine receptors. Trends Pharmacol. Sci. 17:1996;209-213.
171. Prchla E., Plank C., Wagner E., Blaas D., Fuchs R. Virus-mediated release of endosomal content in vitro: Different behavior of adenovirus and rhinovirus serotype 2. J. Cell Biol. 131:1995;111-123.
172. Premack B.A., Schall T.J. Chemokine receptors: Gateways to inflammation and infection. Nat. Med. 2:1996;1174-1178.
173. Pudney J., Song M.J. Electron microscopic analysis of HIV-host cell interactions. Tissue Cell. 26:1994;539-550.
174. Reeves J.D., McKnight A., Potempa S., Simmons G., Gray P.W., Power C.A., Wells T., Weiss R.A., Talbot S. CD4-independent infection by HIV-2 (ROD/B): Use of the 7-transmembrane receptors CXCR4, CCR3 and V28 for entry. Virology. 231:1997;130-134.
175. Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S. The envelope glycoprotein from the tick-borne encephalitis virus at 2 Å resolution. Nature. 375:1995;291-298.
176. Rossmann M.G. Viral cell recognition and entry. Protein Sci. 3:1994;1712-1725.
177. Rothman J.E. Mechanisms of intracellular protein transport. Nature. 372:1994;55-63.
178. Rott R., Klenk H.D., Nagai Y., Tashiro M. Influenza viruses, cell enzymes, and pathogenicity. Am. J. Respir. Crit. Care Med. 152:1995;S16-S19.
179. Rucker J., Samson M., Doranz B.J., Libert F., Berson J.F., Yi Y., Collman R.G., Broder C.C., Vassart G., Doms R.W., Parmentier M. Regions in chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell. 87:1996;437-446.
180. Salminen A., Wahlberg J.M., Lobigs M., Liljestrom P., Garoff H. Membrane fusion process of Semliki Forest virus II: Cleavage-dependent reorganization of the spike protein complex controls virus entry. J. Cell Biol. 116:1992;349-357.
181. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.-M., Saragosti S., Lapouméroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996;722-725.
182. Sattentau Q.J., Moore J.P. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:1991;407-415.
183. Schmelz M., Sodeik B., Ericsson M., Wolffe E.J., Shida H., Hiller G., Griffiths G. Assembly of vaccinia virus: The second wrapping cisterna is derived from the trans Golgi network. J. Virol. 68:1994;130-147.
184. Sears A.E., McGwire B.S., Roizman B. Infection of polarized MDCK cells with herpes simplex virus 1: Two asymmetrically distributed cell receptors interact with different viral proteins. Proc. Natl. Acad. Sci. USA. 88:1991;5087-5091.
185. Shoeman R.L., Kesselmier C., Mothes E., Honer B., Traub P. Non-viral cellular substrates for human immunodeficiency virus type 1 protease. FEBS Lett. 278:1991;199-203.
186. Shoeman R.L., Sachse C., Honer B., Mothes E., Kaufmann M., Traub P. Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin. Am. J. Pathol. 142:1993;221-230.
187. Signoret N., Oldridge J., Pelchen-Matthews A., Klasse P.J., Tran T., Brass L.F., Rosenkilde M.M., Schwartz T.W., Holmes W., Dallas W., Luther M.A., Wells T.N.C., Hoxie J.A., Marsh M. Phorbel esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J. Cell Biol. 139:1997;651-664.
188. Singh I., Helenius A. Role of ribosomes in Semliki Forest virus nucleocapsid uncoating. J. Virol. 66:1992;7049-7058.
189. Skoging U., Vihinen M., Nilsson L., Liljestrom P. Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid. Structure. 4:1996;519-529.
190. Smart E.J., Ying Y.S., Conrad P.A., Anderson R.G. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J. Cell Biol. 127:1994;1185-1197.
191. Smith D.H., Byrn R.A., Marsters S.A., Gregory T., Groopman J.E., Capon D.J. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science. 238:1987;1704-1707.
192. Sodeik B., Doms R.W., Ericsson M., Hiller G., Machamer C.E., van't Hof W., van Meer G., Moss B., Griffiths G. Assembly of vaccinia virus: Role of intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J. Cell Biol. 121:1993;521-542.
193. Sodeik B., Ebersold M.W., Helenius A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 136:1997;1007-1021.
194. Spruce A.E., Iwata A., Almers W. The first milliseconds of the pore formed by a fusogenic viral envelope protein during membrane fusion. Proc. Natl. Acad. Sci. USA. 88:1991;3623-3627.
195. Spruce A.E., Iwata A., White J.M., Almers W. Patch clamp studies of single cell-fusion events mediated by a viral fusion protein. Nature. 342:1989;555-558.
196. Stang E., Kartenbeck J., Parton R.G. Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol. Biol. Cell. 8:1997;47-57.
197. Stegmann T. Membrane fusion: Anchors aweigh. Curr. Biol. 4:1994;551-554.
198. Stegmann T., Delfino J.M., Richards F.M., Helenius A. The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion. J. Biol. Chem. 266:1991;18404-18410.
199. Stegmann T., Morselt H.W.M., Booy F.P., van Breemen J.F.L., Scherphof G., Wilschut J. Functional reconstitution of influenza virus envelopes. EMBO J. 6:1987;2651-2659.
200. Stegmann T., White J.M., Helenius A. Intermediates in influenza induced membrane fusion. EMBO J. 9:1990;4231-4241.
201. Stein B.S., Gowda S.D., Lifson J.D., Penhallow R.C., Bensch K.G., Engleman E.G. pH-Independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell. 49:1987;659-668.
202. Steinhauer D.A., Wharton S.A., Skehel J.J., Wiley D.C., Hay A.J. Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: Evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc. Natl. Acad. Sci. USA. 88:1991;11525-11529.
203. Stevenson M. Portals of entry: Iuncovering HIV nuclear transport pathways. Trends Cell Biol. 6:1996;9-15.
204. Stoorvogel W., Geuze H.J., Strous G.J. Sorting of endocytosed transferrin and asialoglycoprotein occurs immediately after internalization in HepG2 cells. J. Cell Biol. 104:1987;1261-1268.
205. Sugrue R.J., Bahadur G., Zambon M.C., Hall S.M., Douglas A.R., Hay A.J. Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J. 9:1990;3469-3476.
206. Sugrue R.J., Hay A.J. Structural characteristics of the M2 protein of influenza viruses: Evidence that it forms a tetrameric channel. Virology. 180:1991;617-624.
207. Suomalainen M., Liljeström P., Garoff H. Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J. Virol. 66:1992;4737-4747.
208. Suzuki Y., Suzuki T., Matsunaga M., Matsumoto M. Gangliosides as paramyxovirus receptor. Structural requirement of sialo-oligosaccharides in receptors for hemagglutinating virus of Japan (Sendai virus) and Newcastle disease virus. J. Biochem. Tokyo. 97:1985;1189-1199.
209. Swanson J.A., Watts C. Macropinocytosis. Trends Cell Biol. 5:1995;424-428.
210. Tatu U., Helenius A. Interactions between newly synthesized glycoproteins, calnexin and a network of resident chaperones in the endoplasmic reticulum. J. Cell Biol. 136:1997;555-565.
211. Taylor J.A., O'Brien J.A., Lord V.J., Meyer J.C., Bellamy A.R. The RER-localized rotavirus intracellular receptor: A truncated purified soluble form is multivalent and binds virus particles. Virology. 194:1993;807-814.
212. Thelen M., Rosen A., Nairn A.C., Aderem A. Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane. Nature. 351:1991;320-322.
213. Tomasselli A.G., Hui J.O., Adams L., Chosay J., Lowery D., Greenberg B., Yem A., Deibel M.R., Zurcher N.H., Heinrikson R.L. Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus. J. Biol. Chem. 266:1991;14548-14553.
214. Tooze J., Hollinshead M., Reis B., Radsak K., Kern H. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol. 60:1993;163-178.
215. Trkola A., Dragic T., Arthos J., Binley J.M., Olson W.C., Allaway G.P., Cheng-Mayer C., Robinson J., Maddon P.J., Moore J.P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:1996;184-187.
216. Tse F.W., Iwata A., Almers W. Membrane flux through the pore formed by a fusogenic viral envelope protein during cell fusion. J. Cell Biol. 121:1993;543-552.
217. Vainstein A., Hershkovitz M., Israel S., Rabin S., Loyter A. A new method for reconstitution of highly fusogenic Sendai envelopes. Biochim. Biophys. Acta. 773:1984;181-188.
218. Valsesia Wittmann S., Drynda A., Deleage G., Aumailley M., Heard J.M., Danos O., Verdier G., Cosset F.L. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J. Virol. 68:1994;4609-4619.
219. van Deurs B., Petersen O.W., Olsnes S., Sandvig K. The ways of endocytosis. Int. Rev. Cytol. 117:1989;131-177.
220. R.H. Vogel, S.W. Provencher, C.H. von Bonsdorff, M. Adrian, J. Dubochet, Envelope structure of Semliki Forest virus reconstructed from cryo-electron micrographs, Nature (1986) 533-535.
221. Wagner E., Plank C., Zatloukal K., Cotten M., Birnstiel M.L. Influenza virus hemagglutinin-HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine- DNA complexes - Toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA. 89:1992;7934-7938.
222. Wahlberg J.M., Boere W.A., Garoff H. The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation. J. Virol. 63:1989;4991-4997.
223. Wahlberg J.M., Bron R., Wilschut J., Garoff H. Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein. J. Virol. 66:1992;7309-7318.
224. Wahlberg J.M., Garoff H. Membrane fusion process of Semliki Forest virus I: Low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells. J. Cell Biol. 116:1992;339-348.
225. A. Walter, O. Eidelman, M. Ollivon, R. Blumenthal, Functional Reconstitution of Viral Envelopes, Marcel Dekker, New York, 1990, pp. 395-408.
226. 2 protein - Characterization of the amantadine block. J. Virol. 67:1993;5585-5594.
227. Wang H., Dechant E., Kavanaugh M., North R.A., Kabat D. Effects of ecotropic murine retroviruses on the dual-function cell surface receptor/basic amino acid transporter. J. Biol. Chem. 267:1992;23617-23624.
228. Wang K.S., Kuhn R.J., Strauss E.G., Ou S., Strauss J.H. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J. Virol. 66:1992;4992-5001.
229. Watts C., Marsh M. Endocytosis: What goes in and how? J. Cell Sci. 103:1992;1-8.
230. +-induced insertion of influenza hemagglutinin HA2 N-terminal segment into viral membrane. J. Biol. Chem. 269:1994;18353-18358.
231. Weis W., Brown J.H., Cusack S., Paulson J.C., Skehel J.J., Wiley D.C. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature. 333:1988;426-431.
232. Weiss C.D., Levy J.A., White J.M. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. J. Virol. 64:1990;5674-5677.
233. Weiss R.A., Tailor C.S. Retrovirus receptors. Cell. 82:1995;531-533.
234. Wells T.N.C., Proudfoot A.E.I., Power C.A., Marsh M. Chemokine receptors - The new frontier for AIDS research. Chem. Biol. 3:1996;603-609.
235. Wengler G., Gros C., Wengler G. Analyses of the role of structural changes in the regulation of uncoating and assembly of alphavirus cores. Virology. 222:1996;123-132.
236. Wengler G., Wurkner D., Wengler G. Identification of a sequence element in the alphavirus core protein which mediates interaction of cores with ribosomes and the disassembly of cores. Virology. 191:1992;880-888.
237. Wharton S.A., Calder L.J., Ruigrok R., Skehel J.J., Steinhauer D.A., Wiley D.C. Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J. 14:1995;240-246.
238. White J., Helenius A. pH-dependent fusion between the Semliki forest virus membrane and liposomes. Proc. Natl. Acad. Sci. USA. 77:1980;3273-3277.
239. White J., Kielian M., Helenius A. Membrane fusion proteins of enveloped viruses. Q. Rev. Biophys. 16:1983;151-195.
240. White J.M. Membrane fusion. Science. 258:1992;917-924.
241. White J.M., Wilson I.A. Anti-peptide antibodies detect steps in a protein conformational change: Low-pH activation of the influenza virus hemagglutinin. J. Cell Biol. 105:1987;2887-2896.
242. Whitney J.A., Gomez M., Sheff D., Kreis T.E., Mellman I. Cytoplasmic coat proteins involved in endosome function. Cell. 83:1995;703-713.
243. Wickham T.J., Mathias P., Cheresh D.A., Nemerow G.R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 73:1993;309-319.
244. Wild C., Dubay J.W., Greenwell T., Baird T. Jr., Oas T.G., McDanal C., Hunter E., Matthews T. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA. 91:1994;12676-12680.
245. Wild C., Greenwell T., Matthews T. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res. Hum. Retroviruses. 9:1993;1051-1053.
246. Wild C., Oas T., Mcdanal C., Bolognesi D., Matthews T. A synthetic peptide inhibitor of human-immunodeficiency-virus replication - Correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA. 89:1992;10537-10541.
247. Wild C.T., Shugars D.C., Greenwell T.K., McDanal C.B., Matthews T.J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA. 91:1994;9770-9774.
248. Willett B.J., Hosie M.J., Jarrett O., Neil J.C. Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology. 81:1994;228-233.
249. Willett B.J., Hosie M.J., Neil J.C., Turner J.D., Hoxie J.A. Common mechanism of infection by lentiviruses. Nature. 385:1997;587.
250. Williams R.K., Jiang G.S., Holmes K.V. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA. 88:1991;5533-5536.
251. J. Wilschut, R. Bron, The influenza virus hemagglutinin: Membrane fusion activity in whole virions and reconstituted virosomes, in: J. Bentz (Ed.), Viral Fusion Mechanisms, CRC Press, Boca Raton, FL, 1993.
252. Wu L., Gerard N.P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A.A., Desjardin E., Newman W., Gerard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 384:1996;179-183.
253. WuDunn D., Spear P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:1989;52-58.
254. Wykes M.N., Shellam G.R., McCluskey J., Kast W.M., Dallas P.B., Price P. Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection. J. Virol. 67:1993;4182-4189.
255. Yeager C.L., Ashmun R.A., Williams R.K., Cardellichio C.B., Shapiro L.H., Look A.T., Holmes K.V. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature. 357:1992;420-422.
256. Yoshimoto T., Yoshimoto E., Meruelo D. Identification of amino acid residues critical for infection with ecotropic murine leukemia retrovirus. J. Virol. 67:1993;1310-1314.
257. Yu Y.G., King D.S., Shin Y.K. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science. 266:1994;274-276.
258. Zebedee S.L., Lamb R.A. Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions. J. Virol. 62:1988;2762-2772.
259. Zhirnov O.P. Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo- and paramyxoviruses. Virology. 1776:1990;274-279.
260. Zhirnov O.P. Isolation of matrix M1 from influenza viruses by acid-dependent extraction with nonionic detergent. Virology. 186:1992;324-330.
261. Zingler K., Belanger C., Peters R., Agard E., Young J.A. Identification and characterization of the viral interaction determinant of the subgroup A avian leukosis virus receptor. J. Virol. 69:1995;4261-4266.